Alkermes Inc. plc Stock Prediction
AI-powered sentiment analysis and prediction trends for ALKS, updated each market day.
ALKS AI Sentiment
AI predicts Alkermes Inc. plc stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Sector
Exchange
Market Cap
$7,836,222,435
Cap Tier
Employees
2,050
Headquarters
DUBLIN 4, L2
Listed Since
July 16, 1991
Website
ALKS Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ALKS Volatility
Alkermes Inc. plc has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
